I know you *meant* downstream antagonist.
The point is, Benny Boo, that no one that is even remotely familiar with even the basics of neurobiology would ever in a million years write something like "downhill antagonist".
I could go on and on about your rubbish. And I will.
"If it stops glutamate it will stop calcium being produced"
Glutamate does not "produce" calcium! WTF.
"shutting everything down".
Just shut it all down! That would be called death, Benny.
AGN has a much wider neuroprotective mechanism than just NMDA receptor antagonism. It also helps with the calcium of which you seem to be so fond.
Ann: Supplementary NYR-BI03 Study Confirm Strong Cardioprotection, page-39
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.025(10.2%) |
Mkt cap ! $46.40M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.0¢ | 22.0¢ | $256.0K | 1.085M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 67420 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 25083 | 2 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |